112 related articles for article (PubMed ID: 8930031)
1. Autoantibody reactivity in serum of patients with Alzheimer's disease and other age-related dementias.
Schott K; Wormstall H; Dietrich M; Klein R; Batra A
Psychiatry Res; 1996 Jan; 59(3):251-4. PubMed ID: 8930031
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease.
Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N
J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to ganglioside GM1 in patients with Alzheimer's disease.
Chapman J; Sela BA; Wertman E; Michaelson DM
Neurosci Lett; 1988 Mar; 86(2):235-40. PubMed ID: 3368123
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against gangliosides in patients with dementia.
Hatzifilippou E; Koutsouraki E; Costa VG; Baloyannis SJ
Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):660-6. PubMed ID: 24838532
[TBL] [Abstract][Full Text] [Related]
5. Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.
Ariga T; Kubota M; Nakane M; Oguro K; Yu RK; Ando S
PLoS One; 2013; 8(5):e63326. PubMed ID: 23717411
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.
Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M
J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome.
Werle E; Fischer HP; Müller A; Fiehn W; Eich W
J Rheumatol; 2001 Mar; 28(3):595-600. PubMed ID: 11296965
[TBL] [Abstract][Full Text] [Related]
9. Induction of autoantibodies to glutamate in patients with Alzheimer's disease.
Davydova TV; Voskresenskaya NI; Fomina VG; Vetrile LA; Doronina OA
Bull Exp Biol Med; 2007 Feb; 143(2):182-3. PubMed ID: 17970195
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to serotonin in serum of patients with psychiatric disorders.
Schott K; Schaefer JE; Richartz E; Batra A; Eusterschulte B; Klein R; Berg PA; Bartels M; Mann K; Buchkremer G
Psychiatry Res; 2003 Nov; 121(1):51-7. PubMed ID: 14572623
[TBL] [Abstract][Full Text] [Related]
11. Serum aluminum levels in Alzheimer's disease and other senile dementias.
Zapatero MD; Garcia de Jalon A; Pascual F; Calvo ML; Escanero J; Marro A
Biol Trace Elem Res; 1995; 47(1-3):235-40. PubMed ID: 7779552
[TBL] [Abstract][Full Text] [Related]
12. Production of autoantibodies to glutamate during Alzheimer's dementia.
Davydova TV; Voskresenskaya NI; Gorbatov VY; Fomina VG; Doronina OA; Maksunova IV
Bull Exp Biol Med; 2009 Apr; 147(4):405-7. PubMed ID: 19704934
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.
Heinonen O; Syrjänen S; Soininen H; Talasniemi S; Kaski M; Mäntyjärvi R; Syrjänen K; Riekkinen P
Neurosci Lett; 1993 Jan; 149(1):67-70. PubMed ID: 8469384
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
[TBL] [Abstract][Full Text] [Related]
16. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome.
Klein R; Berg PA
Clin Investig; 1994 Jul; 72(7):541-9. PubMed ID: 7981584
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-linked immunosorbent assay for human autoantibody to glial fibrillary acidic protein: higher titer of the antibody is detected in serum of patients with Alzheimer's disease.
Tanaka J; Nakamura K; Takeda M; Tada K; Suzuki H; Morita H; Okado T; Hariguchi S; Nishimura T
Acta Neurol Scand; 1989 Dec; 80(6):554-60. PubMed ID: 2618583
[TBL] [Abstract][Full Text] [Related]
19. Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects.
Lopez OL; Rabin BS; Huff FJ; Rezek D; Reinmuth OM
Stroke; 1992 Aug; 23(8):1078-83. PubMed ID: 1636181
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
